Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.25
BATS BZX Real-Time Price
As of 9:43am ET
 +0.11 / +0.50%
Today’s Change
10.94
Today|||52-Week Range
24.43
+7.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues2.2B2.2B2.2B2.0B
 
 
 
 
 
Cost of Goods Sold602.0M618.0M603.0M530.0M
 
 
 
 
 
Depreciation And Amortization667.0M698.0M819.0M786.0M
 
 
 
 
 
 
Operating ExpensesGross Income964.0M903.0M741.0M679.0M
 
 
 
 
 
General Expenses753.0M704.0M729.0M683.0M
 
 
 
 
 
Research And Development94.0M81.0M90.0M92.0M
 
 
 
 
 
Total Operating Expenses2.0B2.0B2.2B2.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income211.0M199.0M12.0M-4.0M
 
 
 
 
 
Extraordinary Credit49.0M238.0M----
 
 
 
Extraordinary Charge-137.0M-728.0M-274.0M-2.3B
 
 
 
 
 
Interest Expense On Debt459.0M459.0M448.0M416.0M
 
 
 
 
 
Other Expenses91.0M347.0M-97.0M27.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-242.0M-400.0M-804.0M-2.7B
 
 
 
 
 
Income Taxes-205.0M-1.7B-1.3B-3.0M
 
 
 
 
 
Minority Interest-1.0M-1.0M-1.0M-2.0M
 
 
 
 
 
Net Income-38.0M1.3B513.0M-2.7B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS350.1M350.4M348.7M350.7M
 
 
 
 
 
Shares To Calculate EPS Diluted350.1M352.3M353.8M350.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11$3.71$1.46-$7.68
 
 
 
 
 
EPS Diluted-$0.11$3.69$1.45-$7.68